News

Nov 5, 2024

NCC to initiate new research to develop nationwide Clinical Trial Network, LC-SCRUM-CD (Clinical Development), supported by PREMIA and Paradigm, to further accelerate precision medicine for patients.

The National Cancer Center (“NCC”), Precision Medicine Asia Co., Ltd. (“PREMIA”) and Paradigm Health Inc (“Paradigm”), announced the...

Sep 25, 2024

TOKYO and XIAMEN, September 25th, 2024 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia...

Jul 29, 2024

TOKYO and XIAMEN, July 25th, 2024 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...

May 20, 2024

TOKYO and XIAMEN, May 20th, 2024 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd....

Mar 28, 2023

TOKYO and XIAMEN, March 27, 2023 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd....

Dec 21, 2022

Establishing a large-scale lung cancer genomic screening platform in the Asia-Pacific region and promoting precision medicine for lung...

Nov 17, 2022

TOKYO and XIAMEN, November 14th, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...

Aug 9, 2022

TOKYO and XIAMEN, August 9, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd....

Apr 20, 2022

TOKYO and XIAMEN, April 20, 2022 -- Riken Genesis Co., Ltd., (“Rigen Genesis”), Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision...

Feb 24, 2022

TOKYO and XIAMEN, February 23, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...

Jan 14, 2022

Xiamen and Hong Kong, January 13, 2022 -- Amoy Diagnostics Co., Ltd., (“AmoyDx”) and PREMIA Holdings (HK) Limited (“PREMIA”) today...

Aug 17, 2021

TOKYO and XIAMEN, August 17, 2021 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...

Jun 30, 2021

TOKYO and XIAMEN, June 30, 2021 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision...

Nov 23, 2019

Jun 24, 2019

Hong Kong, China -- June 24, 2019 – Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic...

May 31, 2019

The National Cancer Center of Japan (“NCC”) today announced the signing of a collaboration between its Cancer Genomic Screening Project...